Customers who struggle to afford the $1,000-plus list price for weight-loss drugs Zepbound and Wegovy can buy now and pay ...

Novo Nordisk has acquired the global rights to China-based United Laboratories’ triple-agonist weight-loss and diabetes drug ...

Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

Losing weight can improve your health and self-esteem. But shedding excess pounds can also lead to a less desirable side ...

Everyone is talking about different diets that can help you lose weight, but do we really know what works and what doesn't?

Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

Around 5 million American women have PCOS, which plays into weight, reproductive health, and fertility outcomes. Here's ...

If you're losing more hair than usual, you could have a problem. Your diet may be to blame for your thinning mane.

Taylor McDaniels started taking medication to help her lose weight, but it's led to changes to many of her habits, including ...